NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Société Internationale d'Urologie
Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Countries: United States, Canada, Chile, China, Cyprus, Hong Kong, India, Iran
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Sex: MALE
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention Exclusion Criteria: * Non-symptomatic BPH * No treatment prescribed for BPH
- Los Angeles, California, United States
- Toronto, Ontario, Canada
- Montreal, Quebec, Canada
- Montreal, Canada
- La Unión, Chile
- Santiago, Chile
- Hangzhou, China
- Nicosia, Cyprus
- Hong Kong, Hong Kong
- Delhi, India
- Tehran, Iran
- Basra, Iraq
- Florence, Italy
- Rome, Italy
- Meru, Kenya
- Mombasa, Kenya
- Nairobi, Kenya
- Beirut, Lebanon
- Kuala Lumpur, Malaysia
- Kati, Mali
- Mexico City, Mexico
- Makurdi, Nigeria
- Zaria, Nigeria
- Peshawar, Pakistan
- Peshawar, Pakistan
- Doha, Qatar
- Seongnam, South Korea
- Istanbul, Turkey (Türkiye)
- London, United Kingdom
- Southend-on-Sea, United Kingdom